Skip to main content
. 2003 Jun;18(6):450–460. doi: 10.1046/j.1525-1497.2003.20938.x

Logistic Regression Results: Probability of Missed Depression Diagnosis in Medical Chart Among HCSUS Participants with Depression Based on CIDI-SF Results*

N = 538 Adjusted OR (95% CI)
Gender
 Male (reference) 1.00 —
 Female 0.65 (0.36 to 1.17)
 Age, y
 18–25 (reference) 1.00 —
 26–40 3.88 (1.79 to 8.42)
 41–49 3.84 (1.73 to 8.54)
 ≥50 8.74 (2.54 to 30.14)
Race
 White (reference) 1.00 —
 African American 1.34 (0.71 to 2.50)
 Latino 0.83 (0.46 to 1.47)
 Other 2.02 (0.97 to 4.17)
Education
 College or greater (reference) 1.00 —
 Some college 1.70 (0.72 to 4.02)
 High school 2.00 (0.89 to 4.49)
 Less than high school 2.81 (1.15 to 6.89)§
HIV exposure
 Men – sex with men (reference) 1.00 —
 Injection drug use 1.48 (0.96 to 2.30)
 Heterosexual 1.89 (0.90 to 3.95)
 Transfusion/other 0.78 (0.29 to 2.13)
Income, $
 >40,000 (reference) 1.00 —
 10–40,000 0.60 (0.30 to 1.22)
 0–10,000 0.58 (0.25 to 1.32)
Health insurance
 Private/non-HMO (reference) 1.00 —
 None 0.47 (0.19 to 1.17)
 Medicare 0.26 (0.10 to 0.68)
 Medicaid 0.62 (0.24 to 1.57)
 Private–HMO 0.94 (0.28 to 3.16)
Region in U.S.
 Northeast (reference) 1.00 —
 Midwest 3.50 (1.61 to 7.63)
 South 2.02 (1.14 to 3.57)§
 West 1.15 (0.56 to 2.34)
CD4 cell count
 ≥500/mm3 (reference) 1.00 —
 200–500/mm3 1.03 (0.48 to 2.20)
 50–199/mm3 1.02 (0.43 to 2.47)
 <50 /mm3 0.91 (0.39 to 2.12)
AIDS diagnoses, n
 0 (reference) 1.00 —
 1 0.78 (0.43 to 1.42)
 2 0.68 (0.32 to 1.43)
 3 1.65 (0.70 to 3.89)
 ≥4 0.99 (0.50 to 1.96)
HIV patients seen by provider, n
 ≥500 (reference) 1.00 —
 <100 0.47 (0.24 to 0.93)§
 100–499 0.85 (0.51 to 1.42)
Outpatient visits, n
 0–2 (reference)
 3–5 0.75 (0.37 to 1.55)
 6–8 0.58 (0.32 to 1.05)
 ≥9 0.39 (0.24 to 0.65)
*

Among the 2,267 HCSUS patients completing second follow-up survey, 1,874 (83%) had medical records available. Of the 538 patients reporting depression, 299 (55%) had a depression diagnosis in the medical record.

P < .01.

P < .001.

§

P < .05.

HCSUS, HIV Cost and Services Utilization Study.